Hit Identification

Hit Identification is a drug discovery process in which biologically active compounds are initially detected from screening assays, distinguished from related processes by its focus on the primary recognition of low-affinity or low-potency compounds that demonstrate specific activity against a target of interest.

88

Publications

6.5K

Citations

460

Authors

167

Institutions

Publications per year

2017–2026

29

Authors

460

  1. JA
    James A. Wohlschlegel

    University of California, Los Angeles, United States

    2 publications · 1.3K citations

    2

    h-index

  2. JH
    Jing Huang

    University of California, Los Angeles, United States

    2 publications · 1.3K citations

    2

    h-index

  3. YZ
    Yingyao Zhou

    Genomics Institute of the Novartis Research Foundation, United States

    2 publications · 58 citations

    2

    h-index

  4. ZW
    Zhijin Wu

    Brown University, United States

    2 publications · 188 citations

    2

    h-index

  5. JB
    Jürgen Bajorath

    University of Bonn, Germany

    2 publications · 175 citations

    2

    h-index

1–5 of 460

Venues

  1. SLAS DISCOVERY

    14 publications · 998 citations

    13

    h-index

  2. Journal of Chemical Information and Modeling

    JCIM · 11 publications · 642 citations

    11

    h-index

  3. Journal of Medicinal Chemistry

    4 publications · 634 citations

    4

    h-index

  4. Methods in enzymology on CD-ROM/Methods in enzymology

    Book series · 3 publications · 65 citations

    3

    h-index

  5. Talanta

    2 publications · 86 citations

    2

    h-index

1–5